Current Leadership
- Bing Ren
- Allen Wang
- Quan Zhu
- Nathan Zemke
- Agnieszka D'Antonio-Chronowska
- Tiffany Fox
Dr. Nathan Zemke specializes in the use of single-cell technologies to study complex diseases like Alzheimer's, cancer, and diabetes. He earned his PhD from UCLA in 2019 under Dr. Arnold Berk, focusing on epigenetic reprogramming and immune responses to DNA tumor viruses.
During his postdoctoral work with Dr. Bing Ren at UC San Diego, Dr. Zemke has helped further our understanding of gene regulation in neurodegenerative diseases and evolutionary biology. His research exploring the spatial organization of the 3D genome and its role in disease mechanisms has been published in high-impact journals such as Nature, Science and many others.
As Associate Director of Single Cell Genomics at the Center for Epigenomics, Dr. Zemke leads efforts to advance epigenomic platforms, enabling the profiling of the epigenome and 3D genome organization at the single-cell level. His work is crucial in deciphering the molecular mechanisms underlying human diseases, with a focus on how gene regulation and chromatin dynamics influence disease progression and treatment outcomes.
Dr. Zemke’s innovative research and leadership in single-cell genomics place him at the forefront of efforts to translate epigenomic discoveries into therapeutic strategies for complex diseases.